Top Markets
Coin of the day
Biostar Pharmaceuticals, Inc. Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc.

BSPM
Κατάταξη σε μετοχές #42723
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets... Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Τιμή μετοχής
$0.0001
Τελευταίος συγχρονισμός: 2026-08-11
Κεφαλαιοποίηση
$264.00
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
0.00%
Χώρα
CN
Εμπόριο Biostar Pharmaceuticals, Inc. (BSPM)

Κατηγορία

Δείκτης P/B για Biostar Pharmaceuticals, Inc. (BSPM)
Δείκτης P/B στις 2026 TTM: 0
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Biostar Pharmaceuticals, Inc., ο τρέχων δείκτης P/B (TTM) είναι 0. Στο τέλος του 2026, η εταιρεία είχε P/B δείκτη 0.
Ιστορικό P/B για την Biostar Pharmaceuticals, Inc. από 2026 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
Έτος Δείκτης P/B Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Δείκτης P/B Διαφορά Δείκτη P/B Χώρα
- -
DE
- -
DE
- -
JP
- -
CH
5.7207 -
IN